News
Cancer Drug with Better Staying Power and Reduced Toxicity Shows Preclinical Promise
The texaphyrin molecule is designed to be more easily absorbed by cancerous cells than healthy human cells, reducing the drug’s side effects.
The Texas Scientist
20/20 Foresight
So what will the next 50 years bring? Absent a crystal ball, your best bet would be to ask a scientist.
12 Ways Texas Science Innovators Made the Most of this Year
Here are a handful of ways that members of our science and mathematics community brandished their entrepreneurial spirit this year.
Kami Hull Seeks to Make Drugs Faster with Less Waste
Learn about Kami Hull's work as an organic chemist and how she won a prestigious Novartis Early Career Award in Chemistry.
